Skip to content

Checked

State dataHealth

Lasmiditan

Published by State of Virginia 路 Updated 03/24/2026

Last updated
03/24/2026
First published 11/27/2025
Update frequency
Not listed
Formats
Web only
Coverage
Virginia
Statewide

About this dataset

Reyvow (lasmiditan) is a prescription oral tablet medication manufactured by Eli Lilly and Company, available in 50 mg and 100 mg strengths to treat acute migraines. The 200 mg strength has been discontinued. It is a controlled substance (CV schedule). This information was generated using AI and is provided for informational and research purposes only. --- ### 馃敆 Related Datasets - [Lasmiditan](https://odgavaprod.ogopendata.com//dataset/409dacca-c45f-4bc8-8e9b-f2573615b2cf) - *HealthData.Gov* - [Lacosamide](https://odgavaprod.ogopendata.com//dataset/acc1ef46-199e-4100-919f-0df4c7fac3be) - *HealthData.Gov* - [Lisdexamfetamine dimesylate](https://odgavaprod.ogopendata.com//dataset/734daf38-69d5-4e7d-b31a-44c9964d8b7b) - *HealthData.Gov* - [Lisdexamfetamine dimesylate](https://odgavaprod.ogopendata.com//dataset/ebbcf9b2-b845-4e3f-815a-ce6f85429388) - *HealthData.Gov* - [Lacosamide](https://odgavaprod.ogopendata.com//dataset/15a12bf6-7a20-42d8-8788-47bfa15fcb2a) - *HealthData.Gov* ---

Files and access

Links open the official government source

Links open outside websites we do not control.

Details

Platform
CKAN open data portal
Keywords
drug-information, harvested, health-care, medications, prescription-drugs, public-health

More from State of Virginia

All

Similar data from other publishers

Frequently asked questions

Who publishes Lasmiditan?
State of Virginia publishes this dataset on Virginia Open Data Portal.
How often is it updated?
The publisher does not list a schedule. The last update was on 03/24/2026.
How do I download it?
Use the official source link above to view or request the data.

Source: Virginia Open Data Portal 路 Last updated 10/21/2026 路 Listing only; the data stays with the publisher